Maybe you recognise the drill ……. you are tired, your frontline NHS job is tough, there is a list of jobs as long as your arm at home, you still need to book transport to attend this conference, and you’re not sure if work will provide any study funding. But you decide to go for…
This talk was recorded live on the second day at DFTB17 in Brisbane. If you missed out in 2017 then why not book your leave for 2018 now. Tickets are on sale for the pre-conference workshops as well as the conference itself at www.dftb18.com.
The start of 2018 has seen UK hospitals receiving an alert from Public Health England about the rise in cases of suspected scarlet fever. What is the extent of the problem and how good are we at actually diagnosing scarlet fever?
Attending a first-time conference is a bit like watching a softball match as a much talked-about rising ‘star’ batter comes onto the field to face-off against a seasoned pitcher. Will they strike a home run or will they simply get struck out? Most want the batter to do well and may even expect it –…
This blog post is based on a talk I’m giving to a mixed group of adult and paediatric emergency physicians. I was asked to talk about something I thought both groups needed to know. I could have got stuck into the role of steroids in pre-school wheeze or antibiotics in otitis media but they can…
This talk was recorded live at DFTB17 in Brisbane. Watch out for more talks from our inaugural conference in the lead up to DFTB18.. If you haven’t done so yet then book some time off for August and come to Melbourne for our next amazing conference. Check out www.dftb18.com for more details. You can also…
With millions upon millions of journal articles being published every year it is impossible to keep up. Every month we ask some of our friends from PERUKI (Paediatric Emergency Research in UK and Ireland) to point out something that has caught their eye.
Wheeze must be one of the most common paediatric presentations to the emergency department and up till now most of us have been reassuring parents and sending them away without treatment. But should we be doing more? A paper, released just last week, suggests that we could.
This talk was recorded live on the first day at DFTB17 in Brisbane. If you missed out on 2017 then why not book your leave for 2018 now. Tickets are on sale for the pre-conference workshops as well as the conference itself at www.dftb18.com.
On 22nd August 2017, guanfacine hydrochloride (current sole brand name Intuniv) was accepted as a new chemical entity by the Therapeutic Goods Administration in Australia.1 Whilst new to Australia, guanfacine has been available within the United States of America and Europe since 20102 and 20153 respectively. The development of generic brands within these countries has…
This talk was recorded live on the second day at DFTB17 in Brisbane. If you missed out in 2017 then why not book your leave for 2018 now. Tickets are on sale for the pre-conference workshops as well as the conference itself at www.dftb18.com.
Communicating quality at DFTB17
DFTB, T. Communicating quality at DFTB17, Don't Forget the Bubbles, 2018. Available at:
http://doi.org/10.31440/DFTB.15572
This talk was recorded live on the second day at DFTB17 in Brisbane. If you missed out in 2017 then why not book your leave for 2018 now. Tickets are on sale for the pre-conference workshops as well as the conference itself at www.dftb18.com.